MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murthy, K. S.
Right arrow Articles by Makhlouf, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murthy, K. S.
Right arrow Articles by Makhlouf, G. M.

Vol. 54, Issue 1, 122-128, July 1998

Regulation of Adenylyl Cyclase Type V/VI in Smooth Muscle: Interplay of Inhibitory G Protein and Ca2+ Influx

Karnam S. Murthy and Gabriel M. Makhlouf

Departments of Physiology (K.S.M.) and Medicine (G.M.M.), Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298-0711

    Summary
Top
Summary
Introduction
Procedures
Results
Discussion
References

The characteristics of inhibitory regulation of adenylyl cyclase V/VI by Ca2+ and G proteins were examined in dispersed gastric smooth muscle cells. The mechanisms were evoked separately, sequentially, or concurrently using ligand-gated and G protein-coupled receptor agonists and receptor-independent probes (e.g, thapsigargin). During the initial phase of agonist stimulation, alpha ,beta -methylene-ATP, UTP, and ATP inhibited forskolin-stimulated cAMP formation in a concentration-dependent fashion. Inhibition by alpha ,beta -methylene-ATP, which activates ligand-gated P2X receptors, was abolished by zero Ca2+, whereas inhibition by UTP, which activates P2Y2 receptors coupled to Gq/11 and Gi3, was not affected by zero Ca2+ but was abolished by pertussis toxin (PTX). Inhibition by ATP, which activates both P2X and P2Y2 receptors, was not affected by zero Ca2+ alone; but after inhibition mediated by Galpha i3 was blocked with PTX, inhibition by Ca2+ influx was unmasked and was abolished by zero Ca2+. Inhibition by cholecystokinin-8 was observed only during the phase of capacitative Ca2+ influx and was blocked by zero Ca2+. Inhibition by UTP during this phase was not affected by zero Ca2+ alone; but after inhibition mediated by Galpha i3 was blocked with PTX, inhibition by Ca2+ influx was unmasked and was abolished by zero Ca2+. Inhibition of adenylyl cyclase V/VI activity in smooth muscle can be mediated independently by inhibitory G proteins and Ca2+ influx but is exclusively mediated by inhibitory G proteins when both mechanisms are triggered.

    Introduction
Top
Summary
Introduction
Procedures
Results
Discussion
References

Functional regulation of the 10 cloned isoforms of adenylyl cyclase is diverse, with no two isoforms displaying identical regulation (Cooper et al., 1995; Sunahara et al., 1996). Nevertheless, three broad categories can be distinguished comprising (1) types I and VIII, predominantly expressed in neurons and stimulated by submicromolar concentrations of Ca2+ and calmodulin and a more widely expressed type III, stimulated by low micromolar concentrations of Ca2+ (Choi et al., 1992a, 1992b; Xia et al., 1992; Cali et al., 1994), (2) types II, IV, and IX, which are not affected by Ca2+ or inhibited (in the case of types II and IV) by the GTP-binding proteins Gi and Go (Tang and Gilman, 1992; Taussig et al., 1993, 1994; Premont et al., 1996), and (3) types V and VI, which are inhibited by Gi and Go and by submicromolar concentrations of Ca2+ elicited by Ca2+ influx but not by Ca2+ release from intracellular stores (Boyajian et al., 1991; Yoshimura and Cooper, 1992; Chiono et al., 1995; Taussig and Gilman, 1995).

We have shown recently that adenylyl cyclase types V and VI, but not types II, III, or IV, are expressed in gastrointestinal smooth muscle (Murthy and Makhlouf, 1997). The cyclases are inhibited, depending on the agonist, by Gi1, Gi2, Gi3, and Go. Inhibition via somatostatin sst3 receptors is mediated by Gi1 and Go (Murthy et al., 1996), whereas inhibition via opioid µ, delta , or kappa  receptors is mediated by Gi2 and Go (Murthy and Makhlouf, 1996). Inhibition via adenosine A1 receptors, muscarinic m2 receptors, and P2Y2 receptors is mediated by Gi3 (Murthy and Makhlouf, 1995a, 1997, 1998). Stimulation of adenylyl cyclase via muscarinic m3 receptors is mediated by the beta gamma subunit of Gq/11; the stimulation is masked by the predominant inhibition mediated via m2 receptors by Gi3 (Murthy and Makhlouf, 1997).

The coexistence of receptor subtypes coupled to distinct signaling pathways is likely to elicit various patterns of regulation of adenylyl cyclase V/VI in smooth muscle. For example, stimulation of adenylyl cyclase activity by adenosine A2 receptors coupled to Gs is attenuated by A1 receptors coupled to inhibition of adenylyl cyclase via the alpha  subunit of Gi3 and to activation of PLC-beta 3 and IP3-dependent Ca2+ release via the alpha  and beta gamma subunits of Gi3 (Murthy and Makhlouf, 1995a): inhibitory regulation could be mediated by Ca2+ influx, inhibitory G protein, or both. Whether these inhibitory mechanisms operate in concert or are mutually exclusive has not been determined.

In the current study, we examined the characteristics of inhibitory regulation of adenylyl cyclase V/VI by Ca2+ and G proteins in smooth muscle. Experiments were designed in which the mechanisms were evoked separately, sequentially, or concurrently using a variety of agonists and probes. G protein-independent Ca2+ influx was elicited by the P2X receptor agonist alpha ,beta -methylene-ATP (Fredholm et al., 1997; Surprenant et al., 1995), and G protein-dependent and -independent capacitative Ca2+ influx was elicited by agonists (cholecystokinin-octapeptide) and thapsigargin, respectively. Both mechanisms could be elicited concurrently or sequentially with the P2Y2 agonist UTP, which is coupled to both Gq/11 and Gi3 (Harden et al., 1995; Nicholas et al., 1996; Murthy and Makhlouf, 1998), or the mixed P2X and P2Y2 agonist ATP. PTX was used to uncouple P2Y2 receptors from Gi3. The results indicate that inhibition can be independently mediated by Ca2+ influx and inhibitory G proteins, but when both mechanisms are triggered, inhibition is exclusively mediated by inhibitory G proteins.

    Experimental Procedures
Top
Summary
Introduction
Procedures
Results
Discussion
References

Dispersion of smooth muscle cells. Muscle cells were isolated from the circular muscle layer of the rabbit stomach by successive enzymatic digestion, filtration, and centrifugation as described previously (Murthy and Makhlouf, 1997). Briefly, slices of gastric muscle were obtained from the body of circular muscle; the initial slices at the boundaries presumed to contain the majority of interstitial cells of Cajal were discarded. The muscle slices were incubated for 30 min at 31° in 15 ml of HEPES medium containing 0.1% collagenase (type II) and 0.1% soybean trypsin inhibitor. The composition of the medium was 120 mM NaCl, 4 mM KCl, 2.6 mM KH2PO4, 0.6 mM MgCl2, 25 mM HEPES, 14 mM glucose, and 2.1% Eagle's essential amino acid mixture; no Ca2+ was added to the medium. The partly digested tissue was washed with 100 ml of enzyme-free medium and reincubated for 30 min, during which the cells were allowed to disperse spontaneously without tissue trituration. Suspensions of single muscle cells (~20 × 106 cells) were harvested by filtration through 500-µm Nitex mesh. The suspensions were centrifuged twice for 10 min at 350 × g to eliminate cell debris and organelles, in particular, neural membranes as shown previously using [3H]saxitoxin binding (Murthy and Makhlouf, 1994). Muscle cells prepared in this fashion exclude trypan blue (95-98%) and were studied no later than 1-2 hr after dispersion. Muscle cell length ranged in length from 70 to 150 µm.

Measurement of Ca2+ release and uptake in dispersed smooth muscle cells. Ca2+ release and uptake were measured in dispersed muscle cells as described previously (Poggioli and Putney, 1982; Bitar et al., 1986). The muscle cells (107 cells in 10 ml) were incubated in a medium containing 45Ca2+ (10 µCi/ml) and antimycin (10 µM), and Ca2+ uptake into nonmitochondrial Ca2+ stores was measured at intervals for 60 min when a steady state was attained (steady state 45Ca2+ cell content, 2.46 ± 0.12 nmol/106 cells). UTP (10 µM) was added, and 45Ca2+ cell content was measured at intervals for 10 min and expressed in nanomoles or percent change from steady state 45Ca2+ cell content. Decrease in 45Ca2+ cell content during the initial 15-30 sec reflected net Ca2+ release.

Measurement of cAMP in dispersed smooth muscle cells by radioimmunoassay. cAMP was measured in dispersed cells by radioimmunoassay as described previously (Murthy and Makhlouf, 1996 and 1997). Aliquots (0.5 ml) containing 106 cells/ml were incubated with 10 µM forskolin and the test agent in the presence of 10 µM isobutyl methylxanthine, and the reaction was terminated after 60 sec with 6% cold trichloroacetic acid (v/v). The mixture was centrifuged at 2000 × g for 15 min at 4°. The supernatant was extracted three times with 2 ml of diethyl ether and lyophilized. The samples were reconstituted for radioimmunoassay in 500 µl of 50 mM sodium acetate, pH 6.2, and acetylated with triethylamine/acetic anhydride (3:1, v/v) for 30 min. cAMP was measured in duplicate using 100-µl aliquots and expressed as pmol/106 cells.

Experimental design. Several experimental approaches were devised to distinguish between the effects of Ca2+ and inhibitory G proteins. (1) In one set of experiments, forskolin (10 µM) was added to dispersed smooth muscle cells either alone or together with a Ca2+-mobilizing agonist for 60 sec, and cAMP formation during this period was measured. Measurements were made in Ca2+-containing and Ca2+-free medium (0 Ca2+ plus 1 mM EGTA) and in muscle cells preincubated for 60 min with 400 ng/ml PTX. (2) In another set of experiments, the muscle cells were treated for 5 min with a maximally effective concentration of a Ca2+-mobilizing agonist so as to elicit capacitative Ca2+ influx and then were treated with forskolin for 60 sec. Measurements were made in Ca2+-containing and Ca2+-free medium and in muscle cells treated for 10 min with the PLC-beta inhibitor U-73122 or for 60 min with PTX. (3) In control experiments, agonist-independent capacitative Ca2+ influx was elicited by treating the muscle cells with thapsigargin (2 µM) for 30 min in Ca2+-free medium followed by restitution of normal Ca2+; alternatively, the muscle cells were treated with ionomycin (10 µM), which induces both Ca2+ release and Ca2+ influx. Measurements of forskolin-stimulated cAMP formation were made in the presence or absence of Ca2+.

Data analysis. Results were expressed as mean ± standard error and were evaluated statistically using Student's t test for paired or unpaired values.

Materials. [125I]cAMP and 45Ca2+ were obtained from DuPont-New England Nuclear (Boston, MA). HEPES was from Research Organics (Cleveland, OH). Soybean trypsin inhibitor and collagenase (type II) were from Worthington Biochemicals (Freehold, NJ). alpha ,beta -Methylene-ATP and beta ,gamma -methylene-ATP were from Research Biochemicals (Natick, MA). PTX, vinpocetine, U-73122, and thapsigargin were from Calbiochem (San Diego, CA). All other chemicals were from Sigma Chemical (St. Louis, MO).

    Results
Top
Summary
Introduction
Procedures
Results
Discussion
References

The effect of forskolin on cAMP formation and agonist-induced Ca2+ release in dispersed smooth muscle cells. Forskolin caused a prompt increase in cAMP formation above basal level that attained a peak within 1 min declining slowly over a period of 10 min (Fig. 1). CCK-8 had no effect on basal cAMP (basal cAMP, 4.8 ± 0.4 pmol/106 cells; CCK-8, 4.8 ± 0.5 pmol/106 cells) or on forskolin-stimulated cAMP (peak forskolin response, 21.9 ± 2.5 pmol/106 cells above basal level; forskolin plus CCK-8, 21.7 ± 3.8 pmol/106 cells). In contrast, the P2Y2 receptor agonist UTP inhibited forskolin-stimulated cAMP (forskolin plus UTP, 5.5 ± 0.8 pmol/106 cells above basal level); the inhibition by UTP was completely blocked by preincubation of the muscle cells for 60 min with 400 ng/ml PTX.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1.   Time course of forskolin-stimulated cAMP formation in dispersed smooth muscle cells. cAMP formation attained a peak 1 min after addition of forskolin (10 µM) and declined slightly over a 10-min period (bullet ). UTP (10 µM; black-triangle) but not CCK-8 (1 nM; open circle ) inhibited cAMP formation; inhibition by UTP was reversed by preincubation of the muscle cells for 60 min with 400 ng/ml PTX (triangle ). The results are expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.81 ± 0.42 pmol/106 cells). Values are mean ± standard error of three or four experiments.

In muscle cells loaded with 45Ca2+, both CCK-8 (1 nM) and UTP (10 µM) caused prompt release of Ca2+ from sarcoplasmic stores (34 ± 1% and 32 ± 2% decrease in steady state 45Ca2+ cell content in 30 sec, respectively) followed by slower uptake into the stores over a period of 10 min (Fig. 2). Treatment of the cells with 1 µM nifedipine had no significant effect on CCK- or UTP-induced Ca2+ release, which occurred mainly during the first 1-min period, but it blocked Ca2+ reuptake, implying that capacitative Ca2+ influx to replenish the depleted Ca2+ stores is mediated by dihydropyridine-sensitive Ca2+ channels. The results are similar to those obtained previously in smooth muscle cells stimulated with CCK-8 in which methoxyverapamil was shown to block Ca2+ reuptake into the stores (Bitar et al., 1986).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Time course of Ca2+ release and reuptake induced by UTP and CCK-8 in smooth muscle cells. Muscle cells were incubated in a medium containing 45Ca2+ (10 µCi/ml) and antimycin (10 µM), and Ca2+ uptake into nonmitochondrial Ca2+ stores was measured at intervals for 60 min when a steady state 45Ca2+ cell content (2.5-2.8 nmol Ca2+/106 cells) was attained. UTP (10 µM) or CCK-8 (1 nM) was added with or without nifedipine (1 µM) or forskolin (10 µM), and 45Ca2+ cell content was measured at intervals for 10 min. Nifedipine and forskolin had no effect on Ca2+ release (first minute) but inhibited Ca2+ reuptake. Data are mean ± standard error of four experiments. *, p < 0.05, **, p < 0.01 from control levels.

The concomitant addition of forskolin had no effect on CCK- or UTP-induced Ca2+ release during the first minute but abolished capacitative Ca2+ influx into the cells. A comparison of the time course of forskolin-stimulated cAMP and that of agonist-stimulated Ca2+ release in the presence and absence of forskolin suggested that Ca2+ release did not exert an inhibitory effect on cAMP formation in smooth muscle cells expressing adenylyl cyclase V/VI. The inhibitory role of capacitative Ca2+ influx was examined by altering the experimental design as described subsequently.

Differential inhibition of adenylyl cyclase activity by G protein-coupled P2Y receptor and ligand-gated P2X receptor agonists. We have shown recently that the initial increase in [Ca2+]i induced by UTP, a P2Y2 receptor agonist in gastric smooth muscle cells, was mediated by IP3-dependent Ca2+ release, whereas the increase in [Ca2+]i induced by alpha ,beta -methylene-ATP, a P2X1 receptor agonist in these cells, was mediated by Ca2+ influx via voltage-sensitive Ca2+ channels (Murthy and Makhlouf, 1998). The increase in [Ca2+]i induced by ATP, a mixed P2Y2/P2X1 receptor agonist in these cells, was mediated by both Ca2+ release and Ca2+ influx. The P2Y2 receptors were coupled to both Gq/11 and Gi3, and the stimulation of IP3 formation and Ca2+ release resulted from concurrent activation of PLC-beta 1 by Galpha q/11 and PLC-beta 3 by Gbeta gamma i3. The distinctive properties of these agonists were used to evaluate the regulation of adenylyl cyclase V/VI in dispersed gastric smooth muscle cells. Selective adenosine A1 and A2 receptor antagonists [1 µM DPCPX cyclopentyl-1,3-dipropylxanthine and 0.1 µM CGS-15943 (9-chloro-2-(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine] were added to the medium to prevent effects that could result from degradation of purine agonists (Murthy and Makhlouf, 1995a).

The inhibitory effects of alpha ,beta -methylene-ATP, UTP, and ATP on forskolin-stimulated cAMP formation measured during the first 60 sec of agonist stimulation were concentration dependent (Figs. 3-5). Inhibition induced by 10 µM alpha ,beta -methylene-ATP, UTP, and ATP was 39 ± 3%, 53 ± 3%, and 61 ± 5%, respectively. The percentage inhibition of cAMP by 10 µM alpha ,beta -methylene-ATP (48 ± 5%) or UTP (57 ± 6%) was not altered when measurements were done in the presence of a high concentration of IBMX (500 µM) to eliminate the possibility of degradation by Ca2+-stimulated PDE1. The percentage inhibition of cAMP by alpha ,beta -methylene-ATP (47 ± 6%) or UTP (59 ± 7%) also was not altered when measurements were done in the presence of the selective PDE1 inhibitor vinpocetine (100 µM).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3.   Concentration-response curves for alpha ,beta -methylene-ATP-induced inhibition of forskolin-stimulated cAMP formation in smooth muscle cells. The effects of alpha ,beta -methylene-ATP on forskolin-stimulated cAMP formation in dispersed gastric smooth muscle cells were measured during the first 60 sec of agonist stimulation in the presence or absence of extracellular Ca2+ (0 Ca2+/1 mM EGTA) and after treatment with PTX (400 ng/ml) for 1 hr. Forskolin was added either alone or together with the agonist for 1 min. The results were expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.59 ± 0.42 pmol/106 cells; basal level after PTX, 4.51 ± 0.34 pmol/106 cells; basal level in 0 Ca2+, 4.57 ± 0.34 pmol/106 cells). Values are mean ± standard error of four experiments. *, p < 0.02; **, p < 0.01.

Inhibition of cAMP formation by alpha ,beta -methylene-ATP was completely blocked by withdrawal of Ca2+ from the medium (0 Ca2+/1 mM EGTA) but was not affected by pretreatment of the muscle cells for 60 min with 400 ng/ml PTX (Fig. 3). Inhibition induced by combining alpha ,beta -methylene-ATP (10 µM) with CCK-8 (1 nM) (40 ± 6%) was not significantly different from that induced by alpha ,beta -methylene-ATP alone (39 ± 3%). In contrast, inhibition of cAMP formation by UTP was not affected by withdrawal of Ca2+ from the medium but was completely blocked by pretreatment of the muscle cells with PTX (Fig. 4). Inhibition of cAMP formation by ATP was only partly blocked by pretreatment of the muscle cells with PTX (inhibition with 10 µM ATP, 61 ± 5%; inhibition after PTX treatment, 38 ± 2%; p < 0.01 for the difference), whereas withdrawal of Ca2+ from the medium had no significant effect (Fig. 5). Complete blockade of inhibition, however, was achieved by pretreatment of the muscle cells with PTX and withdrawal of Ca2+ from the medium. The inhibition of cAMP formation by ATP after pretreatment with PTX was attributed to Ca2+ influx resulting from activation of P2X receptors because it was completely blocked by withdrawal of Ca2+ from the medium.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 4.   Concentration-response curves for UTP-induced inhibition of forskolin-stimulated cAMP formation in smooth muscle cells. The effects of UTP on forskolin-stimulated cAMP formation in dispersed gastric smooth muscle cells were measured during the first 60 sec of agonist stimulation in the presence or absence of extracellular Ca2+ and after treatment with PTX for 1 hr. Forskolin (10 µM) was added either alone or together with the agonist for 1 min. The results were expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.62 ± 0.36 pmol/106 cells; basal level after PTX, 4.50 ± 0.31 pmol/106 cells; basal level in 0 Ca2+, 4.70 ± 0.42 pmol/106 cells). Values are mean ± standard error of four experiments. **, p < 0.01.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Concentration-response curves for ATP-induced inhibition of forskolin-stimulated cAMP formation in smooth muscle cells. The effects of ATP on forskolin-stimulated cAMP formation in dispersed gastric smooth muscle cells were measured during the first 60 sec of agonist stimulation in the presence or absence of extracellular Ca2+ (0 Ca2+/EGTA) and after treatment with 400 ng/ml PTX for 1 hr. Forskolin (10 µM) was added alone or together with the agonist for 1 min. The results were expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.59 ± 0.36 pmol/106 cells; basal level after PTX, 4.74 ± 0.34 pmol/106 cells; basal level in 0 Ca2+, 4.57 ± 0.38 pmol/106 cells; basal levels in 0 Ca2+ after treatment with PTX, 4.80 ± 0.52 pmol/106 cells). Values are mean ± standard error of four experiments. *, p < 0.05; **, p < 0.01.

Thus, inhibition of adenylyl cyclase activity by UTP during the first minute of agonist stimulation was exclusively mediated by a PTX-sensitive G protein, Gi3, whereas inhibition by alpha ,beta -methylene-ATP was exclusively mediated by Ca2+ influx via voltage-sensitive Ca2+ channels. Inhibition by ATP was mediated by both Gi3 and Ca2+ influx; the effect of Ca2+ influx was seen only after the effect mediated by Gi3 was blocked with PTX.

Inhibition of adenylyl cyclase activity in smooth muscle cells by agonist-dependent capacitative Ca2+ influx. To examine the effects of capacitative Ca2+ influx triggered by depletion of intracellular Ca2+ stores on adenylyl cyclase activity, the design of the experiments was altered as follows. The muscle cells were first treated for 5 min with the agonist so as to evoke capacitative Ca2+ influx, after which 10 µM forskolin was added for 1 min. The two agonists used in these experiments were CCK-8, which activates Gq/11 (Murthy and Makhlouf, 1995b), and UTP, which activates both Gq/11 and Gi3 (Murthy and Makhlouf, 1998) in these cells.

After treatment of muscle cells for 5 min with 1 nM CCK-8 and then with 10 µM forskolin for 1 min, cAMP formation was inhibited by 32 ± 5% (p < 0.01, four experiments) (forskolin alone, 20.4 ± 2.4 pmol cAMP/106 cells; forskolin plus CCK-8, 13.8 ± 1.8 pmol/106 cells) (Fig. 6). The inhibition was abolished by withdrawal of Ca2+ from the medium (0 Ca2+/1 mM EGTA) (forskolin plus CCK in 0 Ca2+, 20.6 ± 2.3 pmol/106 cells). The inhibition also was abolished by 10-min treatment of the muscle cells with the PLC-beta inhibitor U-73122 (20.5 ± 2.5 pmol/106 cells). The pattern implied that cAMP formation was inhibited by capacitative Ca2+ influx because the inhibition was blocked when Ca2+ influx was precluded by withdrawing Ca2+ from the extracellular medium or by preventing IP3-dependent Ca2+ release and, thus, depletion of Ca2+ stores.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 6.   Inhibition of forskolin-stimulated cAMP formation in smooth muscle cells by CCK-induced capacitative Ca2+ influx. The effects of capacitative Ca2+ influx on adenylyl cyclase activity were determined after the smooth muscle cells were treated for 5 min with CCK-8 (1 nM). The cells were treated for 1 min with 10 µM forskolin. U-73122 (10 µM) was used to inhibit PLC-beta activity and IP3-dependent Ca2+ release. The results were expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.51 ± 0.3 pmol/106 cells). Values are mean ± standard error of four experiments. **, p < 0.01.

After treatment of muscle cells for 5 min with UTP (10 µM) and then with 10 µM forskolin for 1 min, cAMP formation was inhibited by 65 ± 4% (p < 0.001, four experiments) (forskolin alone, 20.6 ± 2.3 pmol cAMP/106 cells; forskolin plus UTP, 7.1 ± 0.9 pmol/106 cells) (Fig. 7). The inhibition of cAMP formation was not affected by withdrawal of Ca2+ from the medium (8.1 ± 0.8 pmol/106 cells; 60 ± 4% inhibition) but was partly blocked by pretreatment of the muscle cells for 60 min with PTX (14.0 ± 1.2 pmol/106 cells; 28.6 ± 3.5% inhibition; p < 0.01; four experiments). The inhibition was completely blocked by pretreatment of the muscle cells for 60 min with PTX followed by 5-min treatment with UTP in Ca2+-free medium (19.9 ± 2.3 pmol/106 cells; 3 ± 2% inhibition; p = NS). Inhibition also was completely blocked by pretreatment of the muscle cells for 60 min with PTX followed by treatment with both U-73122 (10 µM) and UTP (20.5 ± 1.9 pmol/106 cells; 1 ± 5% inhibition, p = NS). In comparing the effects of UTP and CCK-8, it is worth noting that U-73122 eliminates all IP3-dependent depletion of the Ca2+ stores, thereby precluding capacitative Ca2+ influx, whereas PTX eliminates only IP3 formation mediated by Gi3 but not that mediated by Gq/11, thus maintaining capacitative Ca2+ influx.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 7.   Inhibition of forskolin-stimulated cAMP formation in smooth muscle cells by UTP-induced capacitative Ca2+ influx. To examine the effects of capacitative Ca2+ influx triggered by depletion of intracellular Ca2+ stores on adenylyl cyclase activity, the muscle cells first were treated for 5 min with the Ca2+ mobilizing agonist UTP (10 µM), after which 10 µM forskolin was added for 1 min. U-73122 (10 µM) was used to inhibit PLC-beta activity and IP3-dependent Ca2+ release. PTX was used to block the inhibition mediated by Galpha i. The results are expressed as pmol of cAMP/106 cells above basal level (basal level, 4.30 ± 0.53 pmol/106 cells). Values are mean ± standard error of four experiments. **, p < 0.01.

Inhibition of adenylyl cyclase activity in smooth muscle cells by agonist-independent capacitative Ca2+ influx. The ability of capacitative Ca2+ influx to inhibit adenylyl cyclase activity was examined further using the sarcoplasmic Ca2+-ATPase inhibitor thapsigargin, which depletes intracellular Ca2+ stores independently of receptor activation (Thastrup, 1990). The muscle cells were incubated for 30 min with 2 µM thapsigargin in 0 Ca2+ plus 1 mM EGTA, followed by restitution of control Ca2+ levels (2 mM), and then treated with 10 µM forskolin for 1 min. In muscle cells treated with thapsigargin followed by restitution of extracellular Ca2+, forskolin-stimulated cAMP formation was inhibited by 41 ± 3% (forskolin alone, 18.4 ± 2.1 pmol/106 cells; forskolin plus thapsigargin, 11.4 ± 1.7 pmol/106 cells; p < 0.01, n = 4) (Fig. 8). Inhibition was not observed when the muscle cells were maintained in Ca2+-free medium after treatment with thapsigargin (18.8 ± 1.6 pmol/106 cells).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 8.   Inhibition of forskolin-stimulated cAMP formation in smooth muscle cells by thapsigargin- and ionomycin-induced Ca2+ influx. Top, cAMP was measured before and after treatment with the sarcoplasmic Ca2+/ATPase inhibitor thapsigargin. Muscle cells were incubated for 30 min with 2 µM thapsigargin in 0 Ca2+/1 mM EGTA and then treated with 10 µM forskolin for 1 min in either the presence of 2 mM Ca2+ or absence of Ca2+. Bottom, The muscle cells were treated for 1 min with 10 µM ionomycin and 10 µM forskolin in the presence or absence of Ca2+. The results were expressed as pmol of cAMP/106 cells above basal levels (basal level, 4.62 ± 0.49 pmol/106 cells; basal level after thapsigargin treatment, 4.76 ± 0.31 pmol/106 cells; basal level in 0 Ca2+/1 mM EGTA, 4.70 ± 0.35 pmol/106 cells). Values are mean ± standard error of four experiments. **, p < 0.01.

Similar results were obtained in experiments with ionomycin, which acts as both ionophore and stimulant of Ca2+ release (Murthy et al., 1991). The muscle cells were treated for 1 min with 10 µM ionomycin and 10 µM forskolin in the presence or absence of Ca2+. In muscle cells treated with ionomycin in the presence of 2 mM Ca2+, forskolin-stimulated cAMP formation was inhibited by 40 ± 4% (forskolin alone, 18.4 ± 2.1 pmol/106 cells; forskolin plus ionomycin in 2 mM Ca2+,10.9 ± 1.7 pmol/106 cells; p < 0.01, four experiments) (Fig. 8). Inhibition was not observed in the absence of Ca2+ (forskolin in 0 Ca2+, 18.2 ± 1.8 pmol/106 cells; forskolin plus ionomycin in 0 Ca2+, 18.0 ± 2.0 pmol/106 cells). The inhibitory effect of ionomycin during this short interval seemed to reflect its ability to stimulate Ca2+ influx.

    Discussion
Top
Summary
Introduction
Procedures
Results
Discussion
References

The results of the current study show the operation of two distinct mechanisms for the inhibitory regulation of adenylyl cyclase types V/VI in smooth muscle cells: a G protein-dependent mechanism and a Ca2+-dependent mechanism that seems to operate only in the absence of inhibitory G protein regulation. The mechanisms could be activated separately by agonists acting on G protein-coupled receptors (UTP, ATP, CCK-8) and ligand-gated receptors (alpha ,beta -methylene-ATP and ATP) and by agents that bypass receptors, such as the sarcoplasmic Ca2+/ATPase inhibitor, thapsigargin, and ionomycin. The agonists acting on G protein-coupled receptors provided distinctive patterns of G protein activation that facilitated analysis of the role of each inhibitory mechanism. The Ca2+-dependent mechanisms had in common the ability to induce Ca2+ influx via voltage-sensitive Ca2+ channels and did not involve activation of a Ca2+-stimulated PDE1.

During the initial 1-min period of agonist stimulation that coincided with Ca2+ release from intracellular stores, UTP, which activates P2Y2 receptors coupled to Gq/11 and Gi3 in visceral and vascular smooth muscle (Pacaud et al., 1995; Murthy and Makhlouf, 1998), inhibited forskolin-stimulated cAMP formation in a concentration-dependent fashion; the inhibition was blocked by PTX but not by 0 Ca2+, implying that it was mediated exclusively by Galpha i3. CCK-8, which activates receptors coupled to Gq/11 only, had no effect on cAMP formation. alpha ,beta -Methylene-ATP, which selectively activates ligand-gated P2X receptors in smooth muscle cells, causing membrane depolarization and dihydropyridine-sensitive Ca2+ influx (Murthy and Makhlouf, 1998), also inhibited cAMP formation, but in contrast to UTP, the inhibition was blocked by 0 Ca2+ but not by PTX, implying that it was mediated exclusively by Ca2+ influx via voltage-sensitive Ca2+ channels.

The effect of ATP, which activates both G protein-coupled P2Y2 and ligand-gated P2X receptors, demonstrated the preferential operation of the inhibitory mechanism mediated by Gi3. Withdrawal of Ca2+ from the medium had no effect on ATP-induced inhibition of cAMP formation. However, when the inhibitory effect mediated by Gi3 was blocked with PTX, the inhibitory effect of Ca2+ influx mediated by P2X receptors was unmasked and could be blocked by withdrawal of Ca2+ from the medium. The pattern implied that when both mechanisms were elicited by different receptors, adenylyl cyclase activity was preferentially inhibited by the G protein.

Preferential inhibition by G protein also was observed with UTP during the period of capacitative Ca2+ influx, that is, 5 min after exposure to the agonist. Inhibition of forskolin-stimulated cAMP formation during this period was mediated by Gi3 and could be blocked by PTX but not by withdrawal of Ca2+. However, after Gi3-mediated inhibition was blocked with PTX, inhibition by capacitative Ca2+ influx was unmasked and could be blocked by withdrawal of Ca2+ from the medium. This pattern also implied that inhibition of adenylyl cyclase activity was preferentially mediated by the G protein that masked or suppressed the inhibitory effect of capacitative Ca2+ influx. In cell lines (e.g., NCB-20) in which UTP activates P2Y receptors coupled to a PTX-insensitive G protein, inhibition of cAMP formation was mediated by capacitative Ca2+ influx (Garritsen et al., 1992).

The independent inhibitory effect of capacitative Ca2+ influx was seen to best advantage after 5-min treatment with CCK-8 or 30-min treatment with thapsigargin to deplete the Ca2+ stores where inhibition of forskolin-stimulated cAMP formation was abolished by withdrawal of Ca2+ from the medium. Similar inhibition was obtained after 1-min treatment with ionomycin: the effect of the ionophore that induces both Ca2+ influx and Ca2+ release was mediated by Ca2+ influx because it was blocked on withdrawal of Ca2+ from the medium.

It is worth noting that inhibition of adenylyl cyclase V/VI activity by Ca2+ influx in smooth muscle could be elicited whether Ca2+ influx was triggered by (1) activation of ligand-gated P2X receptors/channels (alpha ,beta -methylene-ATP and ATP), (2) capacitative Ca2+ influx resulting from depletion of Ca2+ stores by agonists (CCK, UTP) or thapsigargin, or (3) Ca2+ influx via ionophore (ionomycin). Earlier studies (Bitar et al., 1986) have shown that repletion of Ca2+ stores after agonist (CCK-8) stimulation in smooth muscle cells is mediated by Ca2+ influx via voltage-sensitive Ca2+ channels; this notion was confirmed in the current study with both CCK-8 and UTP as agonists (Fig. 2). More recent studies have shown that activation of P2X receptors results in membrane depolarization and Ca2+ influx via dihydropyridine-sensitive Ca2+ channels (Murthy and Makhlouf, 1998). These channels seem to be the preferred route for inhibition of adenylyl cyclase V/VI in smooth muscle as they are in cardiac muscle, which expresses the same adenylyl cyclase isoforms (Yu et al., 1993; Cooper et al., 1995; Gao et al., 1997). The Ca2+ channels are colocalized with adenylyl cyclase in the plasma membrane of cardiac myocytes, providing a structural basis for the ability of Ca2+ influx to regulate adenylyl cyclase (Gao et al., 1997). The strict requirement for regulation by Ca2+ influx seems to prevail for other isoforms of adenylyl cyclase (e.g., types I, III, VIII) that are stimulated by Ca2+ (Fagan et al., 1996). Membrane colocalization and functional interplay of adenylyl cyclases and Ca2+ channels seem to be maintained even when the cyclases are expressed heterologously. However, neither the mechanism of inhibition of adenylyl cyclase by Ca2+ nor the mechanism by which concurrent inhibition by G protein precludes inhibition by Ca2+ influx have been defined. The absence of binding sites for Ca2+ or calmodulin on adenylyl cyclase seems to preclude competitive interplay between the alpha  subunit of inhibitory G proteins and Ca2+.

In summary, inhibition of adenylyl cyclase V/VI activity in smooth muscle can be mediated by inhibitory G proteins or Ca2+ influx independently of whether the latter is elicited by activation of ligand-gated or G protein-coupled receptors. When both mechanisms are triggered concurrently, inhibition is exclusively mediated by inhibitory G proteins.

    Footnotes

Received December 12, 1997; Accepted March 17, 1998

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grant DK28300.

Send reprint requests to: G. M. Makhlouf, M.D., Ph.D., P.O. Box 980711, Medical College of Virginia, Richmond, VA 23298-0711.

    Abbreviations

IP3, inositol triphosphate; PTX, pertussis toxin; CCK-8, cholecystokinin octapeptide; PLC, phospholipase C; [Ca2+]i, intracellular Ca2+ concentration; PDE, phosphodiesterase; EGTA, ethylene glycol bis(beta -aminoethyl ether)-N,N,N',N'-tetraacetic acid; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.

    References
Top
Summary
Introduction
Procedures
Results
Discussion
References


0026-895X/98/010122-07$3.00/0
MOLECULAR PHARMACOLOGY, 54:122-128 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Murthy, S. Mahavadi, J. Huang, H. Zhou, and W. Sriwai
Phosphorylation of GRK2 by PKA augments GRK2-mediated phosphorylation, internalization, and desensitization of VPAC2 receptors in smooth muscle
Am J Physiol Cell Physiol, February 1, 2008; 294(2): C477 - C487.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Crossthwaite, A. Ciruela, T. F. Rayner, and D. M. F. Cooper
A Direct Interaction between the N Terminus of Adenylyl Cyclase AC8 and the Catalytic Subunit of Protein Phosphatase 2A
Mol. Pharmacol., February 1, 2006; 69(2): 608 - 617.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
K. S. Murthy, H. Zhou, J. Huang, and S. N. Pentyala
Activation of PLC-{delta}1 by Gi/o-coupled receptor agonists
Am J Physiol Cell Physiol, December 1, 2004; 287(6): C1679 - C1687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Sobolewski, K. B. Jourdan, P. D. Upton, L. Long, and N. W. Morrell
Mechanism of cicaprost-induced desensitization in rat pulmonary artery smooth muscle cells involves a PKA-mediated inhibition of adenylyl cyclase
Am J Physiol Lung Cell Mol Physiol, August 1, 2004; 287(2): L352 - L359.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. M. Griffith, A. T. Chaytor, H. J. Taylor, B. D. Giddings, and D. H. Edwards
cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions
PNAS, April 30, 2002; 99(9): 6392 - 6397.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. T. Chaytor, H. J. Taylor, and T. M. Griffith
Gap junction-dependent and -independent EDHF-type relaxations may involve smooth muscle cAMP accumulation
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1548 - H1555.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
K. B. Jourdan, N. A. Mason, L. Long, P. G. Philips, M. R. Wilkins, and N. W. Morrell
Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries
Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1359 - L1369.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Defer, M. Best-Belpomme, and J. Hanoune
Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase
Am J Physiol Renal Physiol, September 1, 2000; 279(3): F400 - F416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. L. Watson, K. L. Jacobson, J. C. Singh, R. Idzerda, S. M. Ott, D. H. DiJulio, S. T. Wong, and D. R. Storm
The Type 8 Adenylyl Cyclase Is Critical for Ca2+ Stimulation of cAMP Accumulation in Mouse Parotid Acini
J. Biol. Chem., May 5, 2000; 275(19): 14691 - 14699.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. M. Griffith, A. T. Chaytor, H. J. Taylor, B. D. Giddings, and D. H. Edwards
cAMP facilitates EDHF-type relaxations in conduit arteries by enhancing electrotonic conduction via gap junctions
PNAS, April 30, 2002; 99(9): 6392 - 6397.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow